In this service
Semaglutide vs tirzepatide: how the trials differ
Semaglutide and tirzepatide are different medicines studied in different trials. A Miami Gardens visit chooses between them from your history, not from a headline.
They are not the same drug
Semaglutide is a GLP-1 receptor agonist. Tirzepatide also acts on the GIP receptor. Comparing them as if the milligrams were interchangeable is a mistake. A 1 mg semaglutide dose is not a 1 mg tirzepatide dose.
Headlines that say one “produces more weight loss” are usually comparing different trials, different weeks, and different doses. That is not a head-to-head result unless the paper actually randomized people to both drugs.
What STEP 1 and SURMOUNT-1 are
STEP 1 studied semaglutide for chronic weight management and was published in the New England Journal of Medicine. SURMOUNT-1 studied tirzepatide and was also published there. The trials do not share one clock. One common summary point is 68 weeks for STEP 1 and 72 weeks for SURMOUNT-1. This page does not reprint mean percent weight loss, because those figures belong next to the paper’s methods, not as a clinic promise.
Sponsor matters when you read them. STEP 1 was a Novo Nordisk program. SURMOUNT-1 was an Eli Lilly program. They are evidence about the medicines, not evidence about this clinic’s patients.
How a clinician chooses
The visit looks at the indication on the label, diabetes or its absence, gastrointestinal tolerance, thyroid and pancreatitis history, and what your plan will actually cover. A larger trial average does not override a reason you should not take that medicine.
If you already take one of them, switching is its own decision. Read the switching page before you assume the next drug starts at the top dose.
All In One Care Solutions is at 16191 NW 57 Ave, Miami Gardens, FL 33014. Didiet Solano, MD, is medical director. Johandra Consuegra, APRN, sees patients on the same team. Call (786) 446-9414. English and Spanish.
Where to read next
Related pages
Questions patients ask
Is tirzepatide better than semaglutide?
They were not studied as the same trial with the same endpoint and the same patients. A clinician can explain what each label and each published trial measured. “Better” is not a clinic slogan.
Can I pick the one with the larger headline number?
No. Eligibility, other medicines, side effects, supply, and coverage decide what is prescribed. Bring both names to the visit if you want them compared for you.